Tags: FDA | approves | generic | multiple | sclerosis | treatment

FDA OK's Generic Multiple Sclerosis Treatment

Image: FDA OK's Generic Multiple Sclerosis Treatment
(Copyright Fotolia)

Friday, 06 Oct 2017 09:01 AM

Mylan NV said the U.S. Food and Drug Administration has approved two doses of its generic version of Teva's Copaxone used to treat patients with relapsing forms of multiple sclerosis.

Shipping of the Glatiramer Acetate 40 mg/mL for 3-times-a-week injection and 20 mg/mL for once-daily injection will begin imminently, the company said.

On Monday, the U.S. FDA announced a series of measures designed to speed to market generic versions of complex drugs such as Mylan's emergency EpiPen, in an effort to address the rising cost of pharmaceuticals.

© 2017 Thomson/Reuters. All rights reserved.

 
1Like our page
2Share
Health-News
Mylan NV said the U.S. Food and Drug Administration has approved two doses of its generic version of Teva's Copaxone used to treat patients with relapsing forms of multiple sclerosis.Shipping of the Glatiramer Acetate 40 mg/mL for 3-times-a-week injection and 20 mg/mL for...
FDA, approves, generic, multiple, sclerosis, treatment
87
2017-01-06
Friday, 06 Oct 2017 09:01 AM
Newsmax Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved